These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25871580)

  • 1. Regulatory guidance gaps associated with clinical sample bioanalysis.
    Tudan C
    Bioanalysis; 2015; 7(6):625-8. PubMed ID: 25871580
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory perspective of biomarker bioanalysis during drug development.
    Yu C; Bashaw ED
    Bioanalysis; 2019 Apr; 11(7):607-610. PubMed ID: 30994006
    [No Abstract]   [Full Text] [Related]  

  • 3. Historical perspective on the development and evolution of bioanalytical guidance and technology.
    Shah VP; Bansal S
    Bioanalysis; 2011 Apr; 3(8):823-7. PubMed ID: 21510754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A community of practice approach to bioanalysis delivery: the role of the Preclinical Bioanalysis and Toxicokinetics department at AstraZeneca.
    Wilson A; Silvester S; Woods K
    Bioanalysis; 2014 May; 6(10):1329-37. PubMed ID: 24958117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.
    Huang Y; Shi R; Gee W; Bonderud R
    Bioanalysis; 2012 Aug; 4(15):1919-31. PubMed ID: 22943622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated bioanalytical laboratory automation: where we came from, where we are and where we are going.
    Shen JX
    Bioanalysis; 2011 Jul; 3(13):1415-8. PubMed ID: 21728764
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation and verification of measurement methods in clinical chemistry.
    Theodorsson E
    Bioanalysis; 2012 Feb; 4(3):305-20. PubMed ID: 22303834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the heterogeneous IT landscape of bioanalytical laboratories to increase efficiency of regulatory reporting and data analysis.
    Bittner N
    Bioanalysis; 2011 Jul; 3(13):1429-32. PubMed ID: 21728766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of an automated GLP final report preparation software solution.
    Elvebak LE
    Bioanalysis; 2011 Jul; 3(13):1421-7. PubMed ID: 21728765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on incurred sample stability (ISS) by GCC.
    Lowes S; LeLacheur R; Shoup R; Garofolo F; Dumont I; Martinez S; Zimmer J; Caturla MC; Couerbe P; Awaiye K; Fatmi S; Farmen R; Sheldon C; Bower J; Fiscella M; Fast D; Cape S; Hulse J; Kamerud J; Zhang T; Pasas-Farmer S; Garofolo W; Moussallie M; Rocci M; Allinson J; Gouty D; Buonarati M; Boudreau N; Pellerin B; Lin J; Xu A; Hayes R; Bouhajib M; Stipancic M; Nicholson R; Nehls C; Warren M; Karnik S; Houghton R; Stovold C; Reuschel S; Cojocaru L; Marcelletti J; Fang X; Smith I; Watson A
    Bioanalysis; 2014 Sep; 6(18):2385-90. PubMed ID: 25384591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of European IVD regulations and its aimed traceability - where are we?
    Delanghe JR; De Buyzere ML
    Clin Chim Acta; 2018 Aug; 483():263-264. PubMed ID: 29752914
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards harmonized regulations for bioanalysis: moving forward!
    van Amsterdam P; Lausecker B; Luedtke S; Timmerman P; Brudny-Kloeppel M
    Bioanalysis; 2010 Apr; 2(4):689-91. PubMed ID: 21083263
    [No Abstract]   [Full Text] [Related]  

  • 13. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-based assessment applied to QA GLP audits. How to fulfill regulatory requirements while making the best use of our common sense, knowledge, talents, and resources?
    Piton A
    Ann Ist Super Sanita; 2008; 44(4):379-84. PubMed ID: 19352000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations from the European Bioanalysis Forum on method establishment for tissue homogenates.
    Timmerman P; Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lentheric I; McIntosh M; Dzygiel P
    Bioanalysis; 2014; 6(12):1647-56. PubMed ID: 25077625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Bioanalysis Forum and the way forward towards harmonized regulations.
    Lausecker B; van Amsterdam P; Brudny-Kloeppel M; Luedtke S; Timmerman P
    Bioanalysis; 2009 Aug; 1(5):873-5. PubMed ID: 21083056
    [No Abstract]   [Full Text] [Related]  

  • 17. Paper-based microfluidic devices in bioanalysis: how far have we come?
    Ge S; Zhang L; Yu J
    Bioanalysis; 2015; 7(6):633-6. PubMed ID: 25871582
    [No Abstract]   [Full Text] [Related]  

  • 18. Singlicate analysis: should this be the default for biomarker measurements using ligand-binding assays?
    Ye Z; Tu J; Midde K; Edwards M; Bennett P
    Bioanalysis; 2018 Jun; 10(12):909-912. PubMed ID: 29923752
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomisation and sample size for clinical audit on infection control.
    Fournel I; Tiv M; Hua C; Soulias M; Astruc K; Aho LS
    J Hosp Infect; 2010 Dec; 76(4):292-5. PubMed ID: 20692069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaboration between monitoring authorities, regulatory authorities and test facilities on GLP principles provides confidence in data quality with an emphasis on sound science. GLP: an example of a focused effort that paid off.
    Grim B; Steeger T
    Ann Ist Super Sanita; 2008; 44(4):359-62. PubMed ID: 19351996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.